Organic compounds -- part of the class 532-570 series – Organic compounds – Chalcogen bonded directly to ring carbon of the purine ring...
Reexamination Certificate
2006-09-12
2006-09-12
Berch, Mark L. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Chalcogen bonded directly to ring carbon of the purine ring...
C544S267000, C544S269000, C544S271000, C544S272000
Reexamination Certificate
active
07105665
ABSTRACT:
Disclosed are methods for making novel A2Badenosine receptor antagonists having the structure of formula I or Formula II:The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.
REFERENCES:
patent: 5776940 (1998-07-01), Daluge et al.
patent: 6977300 (2005-12-01), Kalla et al.
patent: 2005/0187226 (2005-08-01), Wilson et al.
patent: 2005/0261316 (2005-11-01), Kalla et al.
patent: 0956855 (1999-11-01), None
Elzein Elfatih
Ibrahim Prabha
Kalla Rao
Li Xiaofen
Palle Venkata
Berch Mark L.
Clarke Pauline Ann
CV Therapeutics Inc.
Hartrum J. Elin
Lewis Brian
LandOfFree
A 2B adenosine receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A 2B adenosine receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A 2B adenosine receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3595571